Navigation Links
US Oncology Commends Governor Sebelius' Confirmation as U.S. Secretary of Health and Human Services
Date:4/28/2009

Kansas Governor a Strong Choice Due to Experience in Navigating Complex Health Care Access Issues, Working Across Party Lines to Promote Reform

WASHINGTON, April 28 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauds today's Senate confirmation of Kansas Governor Kathleen Sebelius as U.S. Secretary of Health and Human Services (HHS).

"US Oncology is pleased to see Secretary Sebelius take the helm of national health care reform and push for new methods to address the current obstacles restricting access to quality health care for all -- particularly for the more than 10 million Americans now living with cancer," said Roy Beveridge, M.D., Chairman of the US Oncology Public Policy Steering Committee. "We look forward to working closely with Sec. Sebelius and her colleagues to create practical, enduring solutions that address our system challenges while always first advancing the needs of America's cancer patients."

Prior to her appointment as Secretary, Gov. Sebelius established a record of working in a bipartisan manner to promote health care reform during her eight years as Governor and six years as Kansas' insurance commissioner, and helped draft a national patients' bill of rights during her work as commissioner. As HHS Secretary, she will lead the federal government's largest domestic department, overseeing the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), the National Institutes of Health (NIH) and other key health care decision-making agencies.

"Secretary Sebelius will play a chief role in promoting the advancement of sweeping reform measures and technological innovations designed to improve care delivery while lowering costs, such as President Obama's priority to expand the use of heal
'/>"/>

SOURCE US Oncology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
2. Pharmatech Oncology Launches New Data Management Business Unit
3. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
4. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
5. US Oncology Wins Three National Safety Council Awards
6. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
7. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
8. Radiation Oncology Institute (ROI) Campaign Raises $7 Million
9. House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill
10. ACORNs Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
11. US Oncology Reports Fourth Quarter and Yearend 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... formation could boost self-esteem, researchers sa... Autistic children are more likely to have handwri...than those without autism, researchers say. , T...alf of the study participants had autism spectrum ...e normal range for perceptual reasoning on an IQ t...
(Date:11/9/2009)...v. 9 /PRNewswire-FirstCall/ - Hard To Treat Diseas...y that Novartis, a US$41 billion international hea..., H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Phar... of Switzerland will begin a five-year, $1 billion...dramatically increase its investment in its China ...
(Date:11/9/2009)... New study highlights positive influence of sports... Rosemont, IL (Vocus) November 9, 2009 -- As...reases. Recent research has highlighted the import...revent these issues. However, a new study publishe...: A Multidisciplinary Approach reveals that there...
(Date:11/9/2009)...mes 2010 National Ambassador ,, WHITE PLAINS,...ffman of Weston, Fla., was born so early and with ...ot say whether he would survive -- or if he would ...d was named March of Dimes 2010 National Ambassado..."My first minutes of motherhood and I was complete...
(Date:11/9/2009)...people went from incapacitated to working again, ... Electrical stimulation of a certain area of the b...epression, say German researchers. , They impla...he brains of 10 people. This area of the brain is...e remember good experiences and puts them in a sta...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2
...SSEN, Netherlands, May 7 Health ingredients Europ...food & beverage trade show, has been shortlist...est Trade Show Over 2000m2 Award, announced UBM In...ought together 7328 attendees with 450 exhibitors....
...e leader of dementia research in CSIRO,s Preventat...a Szoeke, says the report highlights the challenge...rs predicted to double to 465,000 by 2030. , "Abo...is crisis more effectively." , "By the time suffe...
...g Adults with AD/HD Make a Visit to the Halls of C...rce and Funding for the Mental Health Disorder , ...ll mark the fourth annual national Children,s Ment...ty Disorder (CHADD) and the American Academy of Ch...
...erence Call to Follow Release , , DENVER, May 7 ...the "Company") (OTC Bulletin Board: GLOB), an inte...y, will report its first quarter financial results... http://www.newscom.com/cgi-bin/prnh/20040226/GLO...
...ADELPHIA, May 7 Major League Baseball (MLB) has s...mask legal but banned substances for multi-million...estruction of the game as we know it. Sports team ...fine how the game should be run. , , "MLB is set ...
...ESTER, N.Y., May 7 Recent scientific studies publ...cinogenesis, Oncology, British Journal of Urology,... food extracts Quercetin, EGCG, Glycyrrhizin, and ...nding formulation. Gene-Eden was introduced in Feb...
Other Medicine News:Health News:Health ingredients Europe Shortlisted for AEO's Best Trade Show Over 2000m2 Award 2Health News:Dementia: Early detection is key 2Health News:The New Face of AD/HD Comes to Capitol Hill 2Health News:Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009 2Health News:Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009 3Health News:Is Bailout of Major League Baseball Next? Book Explains How Baseball Like Big Businesses Will Fail 2Health News:The Center for the Biology of Chronic Disease Highlights Anti-Cancer Activities of the Food Extracts Quercetin, EGCG, Glycyrrhizin, and Trans-Cinnamaldehyde 2
(Date:11/9/2009)...wire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Na... the third quarter ended September 30, 2009. ,,...on stockholders in the third quarter of 2009 of $3... loss allocable to common stockholders in the thir...hare, and a net loss allocable to common stockhold...
(Date:11/9/2009)...re/ -- Groundbreaking articles in current issues o...time explore, in depth, the emergence of cannabino...ers and its potential benefits for patients. ,,...gton authors, Sunil Aggarwal, PhD who is a member ...ram and who conducted the article,s research and G...
(Date:11/9/2009)...re/ -- Celling Technologies, a subsidiary of Spine...is, Inc. to research potential applications for ad... acquired the global rights in spine for Tissue Ge...nology in November of 2007. Replacing the prior a...lling Technologies to further research adipose tis...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 1HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 1Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 6
...sdaq: TELK ) reported positive preclinical data f...ecule inhibitors of validated cancer targets,inclu...ented today at the,AACR-NCI-EORTC Conference on Mo...ncisco. Aurora kinases are enzymes that play a ke...-expressed in many human cancers, including breast...
...., a,privately held biopharmaceutical company deve...cular biomarker data demonstrating the overexpress...in in multiple cancers,including ovarian, breast a...ation of PARP overexpression in specific types of ...inical development of the company,s,pipeline of PA...
Other Medicine Technology:Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 2BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: